» Articles » PMID: 9362192

Plasma Vitamin K1 Level is Decreased in Primary Biliary Cirrhosis

Overview
Specialty Gastroenterology
Date 1997 Nov 15
PMID 9362192
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To measure directly plasma vitamin K1 in patients with primary biliary cirrhosis (PBC) and to examine the relationship between vitamin K1 level, prothrombin time, other fat-soluble vitamin levels, and severity of cholestasis.

Methods: We directly measured levels of vitamin K1 (phylloquinone) in the plasma of 77 patients with PBC using reverse-phase high-performance liquid chromatography, along with serum levels of vitamins A, E, and 25-OH vitamin D.

Results: Median plasma vitamin K1 level was significantly lower in PBC patients compared with 255 normal subjects (0.65 nmol/L; range, 0.05-4.13, vs 0.95 nmol/L; range, 0.2-4.92; p < 0.0001). Of 77 PBC patients, 18 (23%) patients had levels below the normal range for plasma vitamin K1 (<0.3 nmol/L). Only 1 of the 18 patients with decreased vitamin K1 had a prolonged prothrombin time. There was no correlation between vitamin K1 level and prothrombin time in the PBC patients (p = 0.75); there was also no difference in prothrombin time between PBC patients with low vitamin K1 level and PBC patients with normal vitamin K1 level (10.3 vs 10.0 seconds; p = 0.28). PBC patients with decreased vitamin K1 levels had significantly lower vitamin A and vitamin E levels, and significantly higher serum bilirubin levels than those with normal vitamin K1 levels.

Conclusion: Decreased plasma vitamin K1 level is common in PBC, and is associated with decreased serum levels of vitamins A and E. However, the majority of PBC patients with decreased plasma vitamin K1 levels have normal prothrombin times. Although the prothrombin time is an insensitive marker of vitamin K1 status in PBC patients, clinically important vitamin K deficiency seems uncommon.

Citing Articles

Elevated Serum KIM-1 in Sepsis Correlates with Kidney Dysfunction and the Severity of Multi-Organ Critical Illness.

Brozat J, Harbalioglu N, Hohlstein P, Abu Jhaisha S, Pollmanns M, Adams J Int J Mol Sci. 2024; 25(11).

PMID: 38892009 PMC: 11172102. DOI: 10.3390/ijms25115819.


Serum vitamins and homocysteine levels in autoimmune liver disease: A systematic review and meta-analysis.

Li J, Tian S, Ci B, Xi Y, Deng X Immun Inflamm Dis. 2024; 12(4):e1258.

PMID: 38652023 PMC: 11037259. DOI: 10.1002/iid3.1258.


Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases.

Espina S, Casas-Deza D, Bernal-Monterde V, Domper-Arnal M, Garcia-Mateo S, Lue A Nutrients. 2023; 15(15).

PMID: 37571424 PMC: 10421025. DOI: 10.3390/nu15153487.


The Role of Vitamin K in Cholestatic Liver Disease.

Sultana H, Komai M, Shirakawa H Nutrients. 2021; 13(8).

PMID: 34444675 PMC: 8400302. DOI: 10.3390/nu13082515.


An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia.

Yang Y, Kim D Int J Mol Sci. 2021; 22(5).

PMID: 33807573 PMC: 7961345. DOI: 10.3390/ijms22052604.